Project Grant H8E38867

Numentus Technologies Inc. received a $303,685 Project Grant award from the National Science Foundation on February 15, 2021 to develop rapid planar PCR technology for COVID-19 testing. The award was made under the NSF's Engineering program (CFDA 47.041) to support innovation and excellence in engineering research. Through this funding, Numentus will work to advance the development of planar PCR, a technology that enables highly sensitive COVID-19 detection on a single integrated testing...

The federal Cooperative Agreement award NU51CK000372, totaling $10,289,496.00, was granted by the National Center for Emerging and Zoonotic Infectious Diseases (part of the CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program. The award will support the New York State Department of Health (NYSDOH) in strengthening its epidemiologic capacity, enhancing laboratory testing capabilities, improving information systems, and fostering collaboration among...

The Centers for Disease Control and Prevention (CDC) awarded the State of Wisconsin Department of Health Services a $3,361,552 Cooperative Agreement under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health (CFDA 93.421) program. The funding supports a 5-year project from August 1, 2024 to July 31, 2029 to enhance the state's capacity for epidemiologic surveillance, laboratory testing, public health informatics, and...

This Cooperative Agreement award of $1,496,617 from the Centers for Disease Control and Prevention (CDC), under the Tribal Public Health Capacity Building and Quality Improvement Umbrella Cooperative Agreement (CFDA 93.772) program, supports a project by the Wyoming Department of Health to bolster the state's epidemiology, laboratory, and health information systems capacity for preventing and controlling emerging infectious diseases. The key products and services to be delivered include:...

The Tennessee Department of Health was awarded a $1,822,620.00 Cooperative Agreement by the Centers for Disease Control and Prevention's (CDC) Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program on August 1, 2024. The five-year award will enhance the state's public health infrastructure and capacity to address emergent situations, capacity deficits, programmatic gaps, and unanticipated events. Key initiatives include expanding syringe service programs to combat Hepatitis...

This Cooperative Agreement award, valued at $2,281,600.00 and spanning August 1, 2024 to July 31, 2029, is provided by the Centers for Disease Control and Prevention (CDC) under the Emerging Infections Programs (CFDA 93.317) federal grant program. The award supports the District of Columbia Department of Health (DC Health) and the DC Department of Forensic Sciences' Public Health Lab in enhancing epidemiologic and laboratory capacity for preventing and controlling emerging infectious diseases....

This $960,000 National Science Foundation project grant supports the development of a multiplexed plasmon-enhanced lateral flow assay for point-of-care detection of SARS-CoV-2 RNA and antigens. Funded under the NSF Engineering program (CFDA 47.041), the grantee, Washington University, will design, validate and build a novel diagnostic platform with sensitivity exceeding standard laboratory tests. Key deliverables include an ultrasensitive multiplexed lateral flow assay for simultaneous...

This Cooperative Agreement award of $760,625 from the National Center for Emerging and Zoonotic Infectious Diseases (part of the Centers for Disease Control and Prevention) was made under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The purpose of the award is to enhance infectious disease epidemiology, laboratory, and entomology capacity, enabling the Mississippi State Department of Health to respond effectively to existing and emerging...

This federal Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323), is valued at $2,518,468 and will run from August 1, 2024 to July 31, 2029. The purpose of the ELC program is to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases through strengthening epidemiological surveillance, laboratory...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program provides $2,254,030.00 to the Ohio Department of Health (ODH) to build and strengthen epidemiology, laboratory, and health information systems to detect, respond, prevent, and control known and emerging infectious diseases in Ohio. The award will enable ODH to work with 111 local health departments across the...